IL17A and benign prostatic hyperplasia: In addition, IL-17 is involved in the progression of BPH, among others through activation of the nuclear-factor-kappa-B (NF-κB) pathway, which leads to the secretion of other pro-inflammatory interleukins, e.g., IL-1, -6 and -8 [14].